Coverage
-
December 19, 2017
A California federal judge gave Sandoz Inc. a quick win Tuesday in a patent infringement suit brought by Amgen Inc. over the biologic Neulasta, finding Sandoz's biosimilar doesn't infringe Amgen's formula.
14 other articles on this case.
View all »